SiPhox

Our mission is to enable new Direct-to-Consumer health and wellness paradigms to address this crisis. We are convinced that everyone will be wearing silicon photonic chips in the future to continuously monitor health biomarkers. We are bringing a next-generation optical chip-based biosensor to market. The reason we are doing this is to drive demand and leverage that to drive our costs down. Our goal is to eventually make it possible to test all these markers in the home instantly at a 10x lower cost. SiPhox’s interdisciplinary team merges biochemistry and photonic chip technology to deliver more biomarker data, faster, and with less blood volume. SiPhox was founded by Diedrik Vermeulen and Michael Dubrovsky one month BC (before Covid) in 2020. SiPhox’s technology enables a next-generation biosensing platform that provides the power a large laboratory instruments in a handheld device that accepts disposable cartridges.